Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
18/5 20:25
Key PointsInitiated 1,446,375-share position in Beam Therapeutics; estimated trade size $40.13 million (quarterly average price)....
18/5 20:25
Key PointsInitiated 1,446,375-share position in Beam Therapeutics; estimated trade size $40.13 million (quarterly average price)....